ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ULVR Unilever Plc

4,133.00
51.00 (1.25%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Unilever Plc LSE:ULVR London Ordinary Share GB00B10RZP78 ORD 3 1/9P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  51.00 1.25% 4,133.00 4,137.00 4,139.00 4,146.00 4,097.00 4,100.00 4,574,072 16:35:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Perfume,cosmetic,toilet Prep 59.6B 6.49B 2.5958 15.94 103.38B
Unilever Plc is listed in the Perfume,cosmetic,toilet Prep sector of the London Stock Exchange with ticker ULVR. The last closing price for Unilever was 4,082p. Over the last year, Unilever shares have traded in a share price range of 3,680.50p to 4,483.00p.

Unilever currently has 2,499,017,983 shares in issue. The market capitalisation of Unilever is £103.38 billion. Unilever has a price to earnings ratio (PE ratio) of 15.94.

Unilever Share Discussion Threads

Showing 1926 to 1943 of 3100 messages
Chat Pages: Latest  88  87  86  85  84  83  82  81  80  79  78  77  Older
DateSubjectAuthorDiscuss
18/1/2022
00:25
eye am fuggin dis custard. May as well fire off another letter to ULVR to register my outrage after sobering up, not that I will get more than a curt reply. To average down or not is the real Q? Got too much invested here to cut and run. Interesting poster yesterday said he sold GSK +6% and bought ULVR -&% sounds like a good idea.
purplepelmets
18/1/2022
00:17
“The market has given a thumbs down to news that Unilever has bid for GlaxoSmithKline̵7;s consumer goods division,” said Russ Mould, investment director at AJ Bell.

“The negative share price reaction probably reflects investors’ fears that Unilever is going to come back with a higher offer and potentially pay too much.

ADVFN market report

philanderer
17/1/2022
23:35
In my view management need to focus on running the existing business and brands efficiently and forget the Mega debt fuelled M&A.
lendmeafiver
17/1/2022
23:20
Reckitt have plenty of healthcare products including Gaviscon, Nurofen, Durex, Clearasil.
justiceforthemany
17/1/2022
20:32
Arguably the better option actually.
pander45
17/1/2022
20:15
For the same amount Jope could take over Reckitt Benckiser.
justiceforthemany
17/1/2022
19:07
It's ultimately not the CEO's call, large institutional investors decide.

Ae per the Netherlands proposal, without support it does not happen.

And as for the CEO's shareholding, you will find the vast, vast majority
are options for which he has not paid a penny for.

essentialinvestor
17/1/2022
18:47
It seems the whole World thinks it knows better than the man running the company.
I doubt that.
This guy is getting a terrible press.

The contrarian in me often does well when I ignore the stupidity of the crowd.

I have not read a single positive argument in support of this deal.

careful
17/1/2022
18:34
CEO's shareholding is worth almost £20 Million here.
justiceforthemany
17/1/2022
16:30
esg doesnt seem to be the problem here in that they appear to be doing that reasonably well and in reality its something picked up from the prior ceo rather than a new idea from the present. in any case, the real issue is the business is at best stagnant. personally think the best way forward here is a shrink to grow approach, a bit like jnj has announced recently. either that or a pe bid which will do much the same but with the spoils favouring the buyer. shareholders would see a premium but that would be it.
roguetraderuk
17/1/2022
16:20
FT- The basic problem with Unilever’s £50bn healthcare bid.
essentialinvestor
17/1/2022
15:43
Unilever should be looking for smaller emerging brands that their enormous global reach can develop, market and grow(Diageo have been doing this for years)Not taking on established brands with limited upside - and don't get me started on the debt ...
panshanger1
17/1/2022
15:37
He won't walk without a huge severance deal.


Idea is a good one, the price ludacris.

Monumental error of judgement on that basis.

essentialinvestor
17/1/2022
15:34
I bought into ULVR as a safe defensive bond like proxy. Not to see management take on hefty debt burden in a rising interest rate world.

So back to basics, pay off debt, grow organically with purchases out of free cash and lastly drop the saving the planet BS, focus on what's best for the business owners, ie the shareholders, us.

Having said that, this deal looks dead and I'm tempted to top up...

thruxie
17/1/2022
15:18
Inevitable.
pander45
17/1/2022
15:14
deal is not going to happen. It needs the large fund shareholders to agree and nothing in it for them. Dead in the water as CEO falls on his sword lol. Expect news in the morning or later after hours. Anybody short will be collecting their big profits.
onehanded
17/1/2022
14:33
All today's brokers update are above £40 so plenty of upside still. Think the next management communication will be more positive for the share price
onehanded
17/1/2022
14:07
I do not think that it was a smart move to do this now.... he should steady the ULVR ship first and prove he can deliver strong results and on the back of it then if wanted take over the GSK unit (or whatever next step)
in the open market after price discovery would have let the market price the asset for a while...


at the moment you have to trust Emma to place your bet... no way.

acsatix
Chat Pages: Latest  88  87  86  85  84  83  82  81  80  79  78  77  Older

Your Recent History

Delayed Upgrade Clock